Agreed, we’ve never produced a vaccine of this type at scale nor managed the required supply chain considerations. Making 10K efficacious non-harmful vaccines f

Agreed, we’ve never produced a vaccine of this type at scale nor managed the required supply chain considerations. Making 10K efficacious non-harmful vaccines for a trial may be much easier than making 100M or 1B. Some processes don’t scale easily.